J Med Life Sci > Volume 7(1); 2010 > Article
Journal of Medicine and Life Science 2010;7(1):35-40.
DOI: https://doi.org/10.22730/jmls.2010.7.1.35    Published online June 30, 2010.
골다공증 치료의 최신지견
이대호
제주대학교 의학전문대학원 내과학교실
The management of osteoporosis
Dae Ho Lee
Department of Internal Medicine, Jeju National University School of Medicine, Jeju, Korea
Correspondence:  Dae Ho Lee, Email: Ldhkso@jejunu.ac.kr
Abstract
The prevention and treatment of osteoporosis is challenging in the elderly. Both early evatuation and proper management are very important to prevent an osteoporotic fracture. Recent development of the newer and stronger anti-resorptive agents is somewhat promising. However, many questions remain with regard to the treatment of osteoporosis; the selection of drugs, the duration of treatment, safety, side effects. Powerful aminobisphosphonate can cause osteonecrosis of the jaw. The increase in bone mineral density due to bisphosphonates accounts for only a quarier of their antifracture action. The evaluation of bone mineral density is not a perfect method. And, blood or urine markers of bone formation or resorption are easily affected by various factors. The follow-up interval after the initiation of drug treatment needs to be settled down. And, other supportive measures also need to be added to manage osteoporosis effectively. This communication discusses about such issues which have been appearing in recent publications.
Key Words: Osteoporosis; Bisphosphonate; Osteonecrosis of the jaw; Bone turnover markers


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
102, Jejudaehak-ro, Jeju-si, Jeju-do 63243, Republic of Korea
Tel: +82-64-754-8023    E-mail: jmls.jeju@gmail.com                

Copyright © 2024 by Jeju National University Institute for Medical Science.

Developed in M2PI

Close layer
prev next